1. Recruiting The "Reach For Health" Program: Delaying Sexual Activity in Children 2. Recruiting "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk 3. Recruiting 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder 4. Recruiting 131MIBG to Treat Malignant Pheochromocytoma 5. Recruiting A 14-day study of Racivir when used in combination in HIV-Infected Males 6. Recruiting 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma 7. Recruiting 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors 8. Recruiting 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas 9. Recruiting 17-DMAG to Treat Patients with Solid Tumors or Lymphomas 10. Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor 11. Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma 12. Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer 13. Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery 14. Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Stage III or Stage IV Melanoma 15. Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer 16. Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors 17. Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia 18. Recruiting 17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease 19. Recruiting 2 doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting 20. Recruiting 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting 21. Recruiting 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors 22. Recruiting A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). 23. Recruiting A 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma 24. Recruiting 3 Different Dose Levels Of CCI-779 In Subjects With Active Rheumatoid Arthritis On Concomitant Methotrexate Therapy 25. Recruiting 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia 26. Recruiting 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors 27. Recruiting 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer 28. Recruiting 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer 29. Recruiting 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer 30. Recruiting 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer 31. Recruiting 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer 32. Recruiting 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies 33. Recruiting 3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas 34. Recruiting 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome 35. Recruiting 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma 36. Recruiting 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction 37. Recruiting 3-D Laser Imaging to Analyze Neck Movement 38. Recruiting 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection 39. Recruiting 4-Day-A-Week Treatment Plan for HIV Infected Adolescents 40. Recruiting 4-PBA: Will it increase the level of Alpha 1-Antitrypsin(AAT) in persons with AAT deficiency? 41. Recruiting 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection 42. Recruiting 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma 43. Recruiting 5HT3 Antagonism and Auditory Gating in Schizophrenia 44. Recruiting A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension 45. Recruiting A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT) 46. Recruiting Abciximab (ReoPro) in Acute Ischemic Stroke 47. Recruiting ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer 48. Recruiting ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma 49. Recruiting ABI-007, Carboplatin, and Trastuzumab in Treating Patients With HER2/neu-Overexpressing Metastatic Breast Cancer 50. Recruiting Absorption and Distribution of Glucosamine and Chondroitin
